Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crocs, Inc. (CROX) vs Quest Diagnostics Inc (DGX) Price & Performance

Crocs, Inc.Trade
Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Crocs, Inc. vs Quest Diagnostics Inc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.63B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.23B). The key difference: Quest Diagnostics Inc is far larger — about 4× Crocs, Inc.'s market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.

CROXDGX
Market Cap
$6.63B$26.23B
Sector
Consumer StaplesHealth
52-Week High
$141.19$238.50
52-Week Low
$73.39$173.49
Enterprise Value
$8.14B$31.99B
Dividend Yield
1.45%

Returns comparison

Trailing returns across standard periods

About Crocs, Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.

Read more on CROX

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX